Featured Unintended pregnancies with levonorgestrel implant due to drug interactions with efavirenz-based ART
1 March 2015. Related: Conference reports, PK and drug interactions, Women's health.
Women’s health
Women, HIV research and antiretrovirals
1 March 2014. Related: Conference reports, Antiretrovirals, Women's health, Cure research.
Improved virological outcomes for women starting efavirenz-based first-line regimens in South Africa
1 March 2014. Related: Conference reports, Women's health.
High rates of pregnancy in HIV positive women in Zambia and South Africa
1 March 2014. Related: Conference reports, PMTCT and maternal health, Women's health.
Contraceptive choices among a Canadian cohort of HIV positive women
1 March 2014. Related: Conference reports, Women's health.
Bone disease and older HIV positive women
1 March 2014. Related: Conference reports, Women's health.
Lower immune response to the qHPV vaccine in HIV positive girls
1 March 2014. Related: Conference reports, Women's health, Paediatric care.
Nevirapine-containing ART does not reduce combined oral contraceptive effectiveness
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health.
Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load
1 February 2013. Related: Conference reports, Women's health, Transmission.
Differences by age for women in response to initial ART: meta-analysis from clinical studies submitted to the FDA
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health.
Lopinavir/ritonavir in pregnancy: results from a systematic review
1 February 2013. Related: Conference reports, Antiretrovirals, PMTCT and maternal health, Women's health.
Possible mechanisms for adverse pregnancy outcomes in HIV positive women
1 February 2013. Related: Conference reports, PMTCT and maternal health, Women's health.
Hormonal contraception and the risk of HIV acquisition
1 November 2012. Related: Conference reports, Women's health.
Hormonal contraception: HIV transmission and progression rates
21 May 2012. Related: Conference reports, Women's health.
Darunavir use during pregnancy
21 May 2012. Related: Conference reports, Antiretrovirals, PK and drug interactions, PMTCT and maternal health, Women's health.
The effect of BMI on efficacy, safety and tolerability of lopinavir/r in women
28 February 2012. Related: Conference reports, Antiretrovirals, Women's health.
Hormonal contraception and higher risk of non-AIDS-defining events in Nashville cohort
28 February 2012. Related: Conference reports, Women's health.
Lopinavir/ritonavir: women versus men
22 January 2011. Related: Conference reports, Antiretrovirals, Women's health.
Quality of life in the GRACE study
22 January 2011. Related: Conference reports, Antiretrovirals, Women's health.
Antiretroviral pharmacokinetics in women with undetectable viral load
22 January 2011. Related: Conference reports, Antiretrovirals, Women's health.
No association between bone mineral density and lipodystrophy in women receiving antiretroviral therapy
22 January 2011. Related: Conference reports, Antiretrovirals, Lipodystrophy and Metabolic Complications, Women's health.
The impact of antiretroviral treatment on fertility intentions in South Africa
22 January 2011. Related: Conference reports, Antiretrovirals, PMTCT and maternal health, Women's health.
Efavirenz-based regimens among women of reproductive age receiving ART in Johannesburg
22 January 2011. Related: Conference reports, Antiretrovirals, PMTCT and maternal health, Women's health.
Gender-based differences in patients receiving antiretroviral therapy
6 January 2010. Related: Conference reports, Antiretrovirals, Women's health.
No clinically relevant interactions between TMC278 and oral contraceptives (norethindrone plus ethinylestradiol)
6 January 2010. Related: Conference reports, Women's health.
Etravirine pregnancy data from five cases: no dose adjustment required
6 January 2010. Related: Conference reports, PMTCT and maternal health, Women's health.
Gender and race differences in lipodystrophy symptoms
1 October 2009. Related: Conference reports, Women's health, Side effects.
Pregnancy rates and outcomes among women in the DART trial
1 July 2009. Related: Conference reports, PMTCT and maternal health, Women's health.
A cost-effectiveness analysis of the OCTANE trial
1 July 2009. Related: Conference reports, PMTCT and maternal health, Women's health.
Results from HSV-2 acyclovir studies
1 July 2009. Related: Conference reports, Opportunistic infections, Women's health, Transmission.
No effect of hormonal contraception on HIV disease progression in large multi-country cohort
22 April 2009. Related: Conference reports, Women's health.
Progression and regression of pre-malignant cervical lesions in HIV-positive women from Soweto
22 April 2009. Related: Conference reports, Women's health.
HAART suppresses genital tract HIV shedding in HIV/HSV co-infected women
22 September 2008. Related: Conference reports, Women's health.
Efavirenz significantly reduces levels of some oral contraceptives
22 September 2008. Related: Conference reports, Women's health.
The unmet need for contraception services for women receiving ART
22 January 2008. Related: Conference reports, Women's health.
Valacyclovir decreases plasma and genital viral loads in HSV-2/HIV-1 co-infected women
22 January 2008. Related: Conference reports, Women's health.
HPV genotypes in HIV-positive women in Zimbabwe and Uganda
22 January 2008. Related: Conference reports, Women's health.